Roopa Industries Ltd

Roopa Industries Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Roopa Industries Ltd

₹ 61.5 -0.95%
10 Jun - close price
roopaindustries.com BSE: 530991
About

Incorporated in 1985, Roopa Industries Ltd is in the business of TPP and its allied products[1]

Key Points

Business Overview:[1][2][3][4]
RIL manufactures Bulk Drugs, Drug Intermediates, Nutraceuticals, and fine chemicals. It produces Active Pharmaceutical Ingredients such as Fluconazole, Sildenafil Citrate, Losartan Potassium and Triphenyl Phosphine (which goes into production of Cephalosporins, Statins etc.,) and Nutraceuticals such as Glucosamine salts.
Its products are used in chemical and pharmaceutical industry and supplied globally

Website BSE
  • Market Cap ₹ 48.4 Cr.
  • Current Price ₹ 61.5
  • High / Low ₹ 115 / 47.3
  • Stock P/E 23.8
  • Book Value ₹ 22.2
  • Dividend Yield 0.00 %
  • ROCE 12.1 %
  • ROE 12.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 2.76 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 10.8% over last 3 years.
  • Earnings include an other income of Rs.2.30 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
16.34 23.12 19.86 15.32 17.87 14.95 14.15 19.24 22.08 34.51 25.61 30.73 29.83
18.52 22.21 18.32 14.02 17.39 13.92 12.45 18.36 21.15 33.46 23.97 29.76 29.39
Operating Profit -2.18 0.91 1.54 1.30 0.48 1.03 1.70 0.88 0.93 1.05 1.64 0.97 0.44
OPM % -13.34% 3.94% 7.75% 8.49% 2.69% 6.89% 12.01% 4.57% 4.21% 3.04% 6.40% 3.16% 1.48%
3.35 0.01 0.03 0.00 0.60 0.00 0.02 0.40 0.71 0.24 0.00 0.92 1.14
Interest 0.35 0.39 0.54 0.65 0.60 0.56 0.69 0.70 0.68 0.79 0.71 0.67 0.66
Depreciation 0.24 0.21 0.21 0.22 0.24 0.23 0.23 0.23 0.19 0.20 0.20 0.26 0.19
Profit before tax 0.58 0.32 0.82 0.43 0.24 0.24 0.80 0.35 0.77 0.30 0.73 0.96 0.73
Tax % 43.10% 28.12% 25.61% 32.56% 4.17% 20.83% 25.00% 25.71% 38.96% 10.00% 19.18% 20.83% 43.84%
0.33 0.22 0.61 0.29 0.23 0.19 0.60 0.27 0.46 0.27 0.58 0.76 0.42
EPS in Rs 0.42 0.28 0.78 0.37 0.29 0.24 0.76 0.34 0.58 0.34 0.74 0.97 0.53
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
29 31 31 30 19 30 28 29 51 76 70 121
29 29 31 28 22 28 26 26 48 72 66 117
Operating Profit -0 2 -1 2 -3 2 2 3 3 4 5 4
OPM % -1% 7% -3% 7% -14% 8% 7% 10% 7% 5% 6% 3%
0 -0 3 0 5 0 1 0 0 1 1 2
Interest 1 1 1 2 1 1 1 1 1 2 3 3
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax -2 0 0 0 0 1 1 1 1 2 2 3
Tax % 3% 11% 35% 56% -22% 24% 54% 24% 26% 25% 30% 25%
-2 0 0 0 1 1 0 1 1 1 2 2
EPS in Rs -2.56 0.20 0.22 0.24 0.69 0.76 0.47 0.92 1.30 1.72 1.93 2.58
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 15%
5 Years: 34%
3 Years: 33%
TTM: 71%
Compounded Profit Growth
10 Years: 21%
5 Years: 41%
3 Years: 26%
TTM: 41%
Stock Price CAGR
10 Years: 27%
5 Years: 43%
3 Years: 27%
1 Year: 9%
Return on Equity
10 Years: 7%
5 Years: 10%
3 Years: 11%
Last Year: 12%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8 8 8 8 8 8 8 8 8 8 8 8
Reserves 1 1 1 2 2 3 3 4 5 6 8 10
8 8 8 11 16 15 14 13 12 19 26 33
7 8 8 8 10 11 14 21 24 24 23 26
Total Liabilities 24 26 25 29 35 36 38 46 49 57 65 76
8 8 7 7 6 6 11 10 10 10 9 8
CWIP 0 0 0 0 2 4 0 0 1 1 1 1
Investments 0 0 0 0 0 0 0 0 0 0 0 0
16 18 18 22 27 26 28 36 39 46 55 68
Total Assets 24 26 25 29 35 36 38 46 49 57 65 76

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1 1 1 -1 -5 4 2 -1 2 -0 -3 -7
-0 -0 0 -0 2 -2 1 1 4 -1 1 2
-0 -0 -1 2 2 -2 -3 -1 -5 2 3 5
Net Cash Flow -0 0 -0 -0 0 0 0 0 1 0 1 0

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 88 66 99 146 233 134 157 147 112 34 43 39
Inventory Days 94 143 70 139 217 171 256 409 140 109 168 121
Days Payable 118 132 100 122 177 123 219 280 86 42 96 56
Cash Conversion Cycle 65 77 69 164 273 182 194 277 166 101 116 104
Working Capital Days 77 87 103 157 307 157 168 173 94 81 116 116
ROCE % -4% 10% 10% 10% 6% 9% 9% 8% 10% 13% 13% 12%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
48.03% 48.03% 48.03% 48.03% 48.03% 48.03% 48.03% 48.03% 48.03% 48.03% 48.03% 48.03%
0.25% 0.00% 0.25% 0.25% 0.25% 0.25% 0.25% 0.25% 0.25% 0.25% 0.25% 0.25%
0.00% 0.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
51.72% 51.72% 51.71% 51.71% 51.72% 51.72% 51.72% 51.73% 51.72% 51.72% 51.71% 51.71%
No. of Shareholders 3,3443,5353,5053,4553,5133,4903,5843,6223,6163,8134,0054,007

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings